Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;63(3):194-8.
doi: 10.1007/s13224-012-0297-7. Epub 2012 Nov 10.

A Comparative Study of CEE, Tibolone, and DHEA as Hormone Replacement Therapy for Surgical Menopause

Bhawna Gupta  1 , Preeti Mittal  1 , Rakesh Khuteta  1 , Adarsh Bhargava  1
Affiliations

A Comparative Study of CEE, Tibolone, and DHEA as Hormone Replacement Therapy for Surgical Menopause

Bhawna Gupta et al. J Obstet Gynaecol India. 2013 Jun.

Abstract

Objectives: The objective of this study was to compare the efficacy and safety of CEE, tibolone, and DHEA for prevention of menopausal symptoms.

Methods: One hundred patients with surgical menopause were included in this study: 25 of whom were not treated with any HRT, 25 were treated with 0.625 mg of CEE, 25 were treated with 2.5 mg of tibolone, and 25 were treated with 25 mg of DHEA for 1 year, and the results were statistically analyzed regarding drug efficacy and side effects at follow-up periods of 1, 6 and 12 months.

Results: Frequency of menopausal symptoms was significantly less in cases received with CEE, tibolone, DHEA with p values 0.001, 0.004 and 0.004, respectively. Percentage gain in BMD was 2.8 % with CEE at lumbar spine, which was greater than that caused by DHEA and tibolone, but this difference was not statistically significant. CEE caused side effects like headache (40 %) and nausea (28 %).

Conclusions: CEE, Tibolone, and DHEA are very effective in alleviating climacteric symptoms. CEE has beneficial effects on lipid and bone and is a low-cost drug but frequently causes side effects. Tibolone offers beneficial androgenic effects on mood and libido with fewer side effects but is a costly drug. DHEA shows positive effects on psychological symptoms. However, its cost and androgenic side effects limit its use as long-term HRT.

Keywords: Climacteric; HRT; Menopause.

PubMed Disclaimer

References

    1. WHO Scientific Group. Research on the menopause. Tech Rep Ser. 1981;670:15–16.
    1. Kokcu A, Cetinkya MG, Yanik F, Alper T, Malatyalioglu E. The comparison of effects of tibolone and conjugated equine estrogen medroxyprogesterone acetate therapy on sexual performance in post menopausal women. Maturitas. 2000;36(1):75–80. doi: 10.1016/S0378-5122(00)00134-1. - DOI - PubMed
    1. Davis SR. The effects of tibolone on mood and libido. Menopause. 2002;9:162–170. doi: 10.1097/00042192-200205000-00004. - DOI - PubMed
    1. Arlt W, Callis F, Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999;341:1013–1020. doi: 10.1056/NEJM199909303411401. - DOI - PubMed
    1. Alexendersen P, Byrjalsen I, Christiansen C. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms and adverse effects. Br J Obstet Gynaecol. 2000;107:356–364. doi: 10.1111/j.1471-0528.2000.tb13231.x. - DOI - PubMed

LinkOut - more resources